Identification/NN
of/IN
Suitable/JJ
Natural/JJ
Inhibitor/NN
against/IN
Influenza/NN
A/NN
(/(
H1N1/NN
)/)
Neuraminidase/NN
Protein/NN
by/IN
Molecular/JJ
Docking/JJ
./.
====================
The/DT
influenza/NN
A/NN
(/(
H1N1/NN
)/)
virus/NN
,/,
also/RB
known/VBN
as/IN
swine/NN
flu/NN
is/VBZ
a/DT
leading/VBG
cause/VBP
of/IN
morbidity/NN
and/CC
mortality/NN
since/IN
2009/CD
./.
====================
There/EX
is/VBZ
a/DT
need/NN
to/TO
explore/VB
novel/JJ
anti-viral/JJ
drugs/NNS
for/IN
overcoming/VBG
the/DT
epidemics/NNS
./.
====================
Traditionally/RB
,/,
different/JJ
plant/JJ
extracts/NNS
of/IN
garlic/JJ
,/,
ginger/JJR
,/,
kalmegh/JJ
,/,
ajwain/RB
,/,
green/VBN
tea/NN
,/,
turmeric/JJ
,/,
menthe/DT
,/,
tulsi/NN
,/,
etc/JJ
./.
====================
have/VBP
been/VBN
used/VBN
as/IN
hopeful/JJ
source/NN
of/IN
prevention/NN
and/CC
treatment/NN
of/IN
human/JJ
influenza/NN
./.
====================
The/DT
H1N1/NN
virus/NN
contains/VBZ
an/DT
important/JJ
glycoprotein/NN
,/,
known/VBN
as/IN
neuraminidase/JJ
(/(
NA/NN
)/)
that/WDT
is/VBZ
mainly/RB
responsible/JJ
for/IN
initiation/NN
of/IN
viral/JJ
infection/NN
and/CC
is/VBZ
essential/JJ
for/IN
the/DT
life/NN
cycle/NN
of/IN
H1N1/NN
./.
====================
It/PRP
is/VBZ
responsible/JJ
for/IN
sialic/JJ
acid/NN
cleavage/NN
from/IN
glycans/NNS
of/IN
the/DT
infected/JJ
cell/NN
./.
====================
We/PRP
employed/VBD
amino/NN
acid/NN
sequence/NN
of/IN
H1N1/NN
NA/NN
to/TO
predict/VB
the/DT
tertiary/JJ
structure/NN
using/VBG
Phyre2/NN
server/RB
and/CC
validated/VBD
using/VBG
ProCheck/NN
,/,
ProSA/NN
,/,
ProQ/NN
,/,
and/CC
ERRAT/NN
server/RB
./.
====================
Further/RB
,/,
the/DT
modelled/JJ
structure/NN
was/VBD
docked/VBN
with/IN
thirteen/DT
natural/JJ
compounds/NNS
of/IN
plant/JJ
origin/NN
using/VBG
AutoDock4.2/NN
./.
====================
Most/JJS
of/IN
the/DT
natural/JJ
compounds/NNS
showed/VBD
effective/JJ
inhibitory/JJ
activity/NN
against/IN
H1N1/NN
NA/NN
in/IN
binding/VBG
condition/NN
./.
====================
This/DT
study/NN
also/RB
highlights/VBZ
interaction/NN
of/IN
these/DT
natural/JJ
inhibitors/NNS
with/IN
amino/NN
residues/NNS
of/IN
NA/NN
protein/NN
./.
====================
Furthermore/RB
,/,
among/IN
13/CD
natural/JJ
compounds/NNS
,/,
theaflavin/DT
,/,
found/VBN
in/IN
green/CD
tea/NN
,/,
was/VBD
observed/VBN
to/TO
inhibit/VB
H1N1/NN
NA/NN
proteins/NNS
strongly/RB
supported/VBD
by/IN
lowest/JJS
docking/NN
energy/NN
./.
====================
Hence/RB
,/,
it/PRP
may/MD
be/VB
of/IN
interest/NN
to/TO
consider/VB
theaflavin/NN
for/IN
further/JJ
in/IN
vitro/FW
and/CC
in/IN
vivo/FW
evaluation/NN
./.
====================
Swine/NN
flu/NN
,/,
also/RB
known/VBN
as/IN
influenza/NN
A/NN
(/(
H1N1/NN
)/)
is/VBZ
an/DT
infectious/JJ
disease/NN
caused/VBD
by/IN
RNA/NN
viruses/NNS
of/IN
the/DT
family/NN
Orthomyxoviridae/NN
[/(
1/CD
]/)
./.
====================
The/DT
H1N1/NN
influenza/NN
virus/NN
arises/VBZ
due/JJ
to/TO
the/DT
genetic/JJ
recombination/NN
of/IN
genes/NNS
from/IN
pig/NN
,/,
human/JJ
,/,
and/CC
bird/JJ
's/POS
H1N1/NN
virus/NN
./.
====================
It/PRP
is/VBZ
unevenly/RB
spherical/JJ
and/CC
is/VBZ
enveloped/VBN
by/IN
a/DT
lipid/NN
membrane/NN
containing/VBG
two/CD
glycoproteins/NNS
namely/RB
hemagglutinin/NN
(/(
HA/NN
)/)
and/CC
neuraminidase/NN
(/(
NA/NN
)/)
[/(
1/CD
]/)
,/,
which/WDT
are/VBP
responsible/JJ
for/IN
viral/JJ
infection/NN
[/(
2/CD
]/)
./.
====================
HA/NN
helps/VBZ
in/IN
attachment/NN
of/IN
the/DT
viral/JJ
strain/NN
on/IN
the/DT
host/NN
cell/NN
surface/NN
and/CC
is/VBZ
needed/VBN
for/IN
infection/NN
,/,
while/IN
NA/NN
is/VBZ
responsible/JJ
initiation/NN
of/IN
viral/JJ
infection/NN
by/IN
cleaving/VBG
of/IN
sialic/JJ
acid/NN
from/IN
glycans/NNS
of/IN
the/DT
infected/JJ
cell/NN
[/(
34/CD
]/)
./.
====================
As/IN
these/DT
two/CD
glycoproteins/NNS
are/VBP
very/RB
essential/JJ
for/IN
viral/JJ
infection/NN
,/,
these/DT
can/MD
be/VB
considered/VBN
as/IN
excellent/JJ
drug/NN
targets/NNS
for/IN
the/DT
control/NN
of/IN
viral/JJ
influenza/NN
,/,
including/VBG
H1N1/NN
./.
====================
Although/IN
oseltamivir/JJ
and/CC
zanamivir/NN
,/,
two/CD
NA/NN
inhibitors/NNS
approved/JJ
for/IN
treatment/NN
and/CC
prevention/NN
of/IN
influenza/NN
[/(
56/CD
]/)
,/,
more/RBR
effective/JJ
natural/JJ
medications/NNS
are/VBP
required/VBN
for/IN
preventing/VBG
the/DT
wide/JJ
spread/VBN
of/IN
swine/NN
flu/NN
./.
====================
There/EX
are/VBP
many/JJ
plant/JJ
products/NNS
traditionally/RB
used/VBN
for/IN
treatment/NN
of/IN
common/JJ
cold/JJ
that/DT
provide/VBP
relief/JJ
from/IN
symptoms/NNS
,/,
including/VBG
sore/RB
throat/IN
,/,
sneezing/VBG
,/,
nasal/JJ
congestion/NN
and/CC
blocked/VBD
nose/DT
[/(
7/CD
]/)
./.
====================
Most/JJS
of/IN
them/PRP
are/VBP
plant/JJ
extracts/NNS
and/CC
the/DT
exact/JJ
mechanism/NN
of/IN
action/NN
are/VBP
yet/RB
to/TO
be/VB
fully/RB
understood/VBN
./.
====================
The/DT
interaction/NN
profile/NN
of/IN
the/DT
active/JJ
compounds/NNS
of/IN
those/DT
plant/JJ
extracts/NNS
with/IN
viral/JJ
proteins/NNS
are/VBP
need/VBN
to/TO
be/VB
explored/VBN
further/RBR
,/,
so/RB
as/IN
to/TO
design/VB
novel/JJ
drugs/NNS
of/IN
natural/JJ
origin/NN
which/WDT
could/MD
be/VB
possibly/RB
used/VBN
effectively/RB
in/IN
prevention/NN
or/CC
treatment/NN
of/IN
H1N1/NN
influenza/NN
without/IN
any/DT
adverse/JJ
effects/NNS
./.
====================
There/EX
are/VBP
many/JJ
plant/JJ
products/NNS
traditionally/RB
used/VBN
for/IN
treatment/NN
of/IN
influenza/NN
infection/NN
among/IN
them/PRP
few/JJ
natural/JJ
compounds/NNS
such/JJ
as/IN
allicin/RB
,/,
ajoene/NN
,/,
andrographolide/CC
,/,
baicalin/NN
,/,
carvacrol/JJ
,/,
catechin/NN
,/,
coumarin/NN
,/,
curcumin/NN
,/,
menthol/JJ
,/,
eugenol/JJ
,/,
theaflavin/DT
,/,
ursolic/JJ
acid/NN
,/,
and/CC
tinosporon/NN
have/VBP
been/VBN
reported/VBN
to/TO
act/VB
against/IN
human/JJ
influenza/NN
./.
====================
The/DT
active/JJ
constituents/NNS
of/IN
the/DT
essential/JJ
oil/JJ
from/IN
the/DT
fruit/NN
of/IN
Trachyspermum/JJ
ammi/NN
are/VBP
thymol/NN
and/CC
carvacrol/NN
[/(
8/CD
]/)
./.
====================
The/DT
essential/JJ
oil/JJ
has/VBZ
strong/JJ
antiseptic/JJ
,/,
antispasmodic/JJ
,/,
aromatic/JJ
,/,
bitter/NN
,/,
diaphoretic/JJ
,/,
digestive/JJ
,/,
diuretic/JJ
,/,
expectorant/JJ
,/,
and/CC
tonic/JJ
[/(
9/CD
]/)
./.
====================
Also/RB
,/,
it/PRP
is/VBZ
used/VBN
for/IN
the/DT
treatment/NN
of/IN
cold/JJ
,/,
cough/IN
,/,
influenza/NN
,/,
and/CC
asthma/NN
[/(
10/CD
]/)
./.
====================
The/DT
Ocimum/JJ
sanctum/NN
have/VBP
great/JJ
Ayurvedic/JJ
treatment/NN
option/NN
for/IN
swine/NN
flu/NN
./.
====================
The/DT
main/JJ
chemical/JJ
constituents/NNS
of/IN
O./NNP
sanctum/NN
are/VBP
oleanolic/JJ
acid/NN
,/,
ursolic/JJ
acid/NN
,/,
rosmarinic/JJ
acid/NN
,/,
eugenol/JJ
,/,
carvacrol/JJ
,/,
linalool/NN
,/,
and/CC
Î²-caryophyllene/NN
[/(
11/CD
]/)
./.
====================
The/DT
antimicrobial/JJ
properties/NNS
of/IN
O./NNP
sanctum/NN
make/VBP
it/PRP
useful/JJ
for/IN
the/DT
prevention/NN
of/IN
novel/JJ
H1N1/NN
flu/NN
./.
====================
Basil/NN
is/VBZ
safe/JJ
,/,
with/IN
no/DT
side/JJ
effects/NNS
and/CC
is/VBZ
great/JJ
to/TO
prevent/VB
swine/NN
flu/NN
from/IN
spreading/NN
like/IN
wildfire/JJ
[/(
12/CD
]/)
./.
====================
Zingiber/NN
officinalis/VBZ
(/(
ginger/JJR
)/)
has/VBZ
been/VBN
reported/VBN
as/IN
the/DT
natural/JJ
remedies/VBZ
for/IN
swine/NN
flu/NN
prevention/NN
./.
====================
The/DT
active/JJ
compounds/NNS
present/JJ
in/IN
ginger/JJR
are/VBP
allicin/NN
,/,
alliin/DT
,/,
and/CC
ajoene/NN
etc/NN
and/CC
the/DT
compound/NN
allicin/NN
has/VBZ
been/VBN
reported/VBN
to/TO
have/VB
anti-influenza/JJ
cytokine/NN
[/(
13/CD
]/)
./.
====================
Allium/DT
sativum/JJ
(/(
garlic/JJ
)/)
has/VBZ
natural/JJ
antiviral/JJ
,/,
antibacterial/JJ
,/,
and/CC
immune-boosting/JJ
properties/NNS
and/CC
has/VBZ
been/VBN
used/VBN
for/IN
hundreds/VBZ
of/IN
years/NNS
to/TO
treat/VB
fungal/JJ
,/,
parasitic/JJ
,/,
and/CC
viral/JJ
infections/NNS
,/,
and/CC
has/VBZ
anti-inflammatory/JJ
properties/NNS
and/CC
it/PRP
is/VBZ
reported/VBN
to/TO
kill/VB
influenza/NN
virus/NN
in/IN
vitro/FW
condition/NN
[/(
14/CD
]/)
./.
====================
The/DT
active/JJ
compound/NN
found/VBN
in/IN
fresh/JJ
garlic/JJ
is/VBZ
ajoene/JJ
./.
====================
Curcumin/NN
,/,
the/DT
active/JJ
constituents/NNS
of/IN
Curcuma/NN
longa/RBR
(/(
turmeric/JJ
)/)
,/,
is/VBZ
reported/VBN
to/TO
have/VB
strong/JJ
antioxidant/JJ
with/IN
antiinflammatory/JJ
,/,
anti-viral/JJ
properties/NNS
[/(
15/CD
]/)
./.
====================
Tinospora/NN
cordifolia/NN
having/VBG
active/JJ
compound/NN
tinosporon/NN
,/,
tinosporic/JJ
acid/NN
,/,
and/CC
syringen/NN
prevent/VBP
swine/NN
flu/NN
./.
====================
The/DT
plant/JJ
has/VBZ
immense/JJ
potential/JJ
for/IN
use/NN
against/IN
novel/JJ
H1N1/NN
flu/NN
since/IN
it/PRP
is/VBZ
a/DT
potent/JJ
immunostimulant/JJ
[/(
16/CD
]/)
./.
====================
The/DT
principal/JJ
components/NNS
of/IN
the/DT
oil/JJ
of/IN
Mentha/NN
piperita/NN
are/VBP
menthol/JJ
(/(
29/CD
%/NN
)/)
,/,
menthone/NN
(/(
20/CD
%/NN
to/TO
30/CD
%/NN
)/)
,/,
and/CC
menthyl/JJ
acetate/NN
(/(
3/CD
%/NN
to/TO
10/CD
%/NN
)/)
./.
====================
Menthol/NN
has/VBZ
antimicrobial/JJ
and/CC
antiviral/JJ
activity/NN
and/CC
also/RB
observed/VBN
to/TO
have/VB
virucidal/JJ
against/IN
influenza/NN
,/,
herpes/RB
,/,
and/CC
other/JJ
viruses/NNS
in/IN
vitro/FW
[/(
17/CD
]/)
./.
====================
Green/NN
tea/NN
is/VBZ
particularly/RB
rich/JJ
in/IN
polyphenolic/JJ
compounds/NNS
like/IN
theaflavin/DT
and/CC
catechins/NNS
./.
====================
Catechin/NN
and/CC
theaflavin/NN
derivatives/NNS
have/VBP
shown/VBN
pronounced/JJ
antiviral/JJ
activity/NN
./.
====================
Green/IN
tea/NN
has/VBZ
the/DT
ability/NN
to/TO
enhance/VB
humoral/JJ
and/CC
cell-mediated/JJ
immunity/NN
and/CC
therefore/RB
,/,
useful/JJ
for/IN
preventing/VBG
influenza/NN
by/IN
inhibiting/VBG
flu/NN
replication/NN
using/VBG
potentially/RB
directs/VBZ
virucidal/JJ
effect/NN
[/(
718/CD
]/)
./.
====================
In/IN
the/DT
current/JJ
study/NN
,/,
we/PRP
performed/VBD
docking/VBG
analysis/NN
to/TO
explore/VB
the/DT
atomic/JJ
interaction/NN
and/CC
molecular/JJ
mechanism/NN
between/IN
13/CD
plants/NNS
originated/VBN
active/JJ
compounds/NNS
such/JJ
as/IN
allicin/RB
,/,
ajoene/RB
,/,
andrographolide/CC
,/,
baicalin/NN
,/,
carvacrol/JJ
,/,
catechin/NN
,/,
coumarin/NN
,/,
curcumin/NN
,/,
menthol/JJ
,/,
eugenol/JJ
,/,
theaflavin/DT
,/,
tinosporon/NN
,/,
and/CC
ursolic/JJ
acid/NN
against/IN
NA/NN
protein/NN
of/IN
H1N1/NN
./.
====================
This/DT
study/NN
comprises/VBZ
of/IN
protein/NN
structure/NN
modeling/VBG
of/IN
NA/NN
using/VBG
Phyre2/NN
server/RB
followed/VBN
by/IN
structural/JJ
refinement/JJ
and/CC
energy/NN
minimization/NN
by/IN
Yet/RB
Another/DT
Scientific/JJ
Artificial/JJ
Reality/NN
Application/NN
(/(
YASARA/NN
)/)
energy/NN
minimization/NN
server/RB
./.
====================
Auto-Dock4.2/NN
tool/NN
was/VBD
used/VBN
to/TO
analyze/VB
the/DT
molecular/JJ
interaction/NN
between/IN
NA/NN
with/IN
natural/JJ
ligands/NNS
./.
====================
Neuraminidase/NN
of/IN
H1N1/NN
====================
NA/NN
protein/NN
of/IN
H1N1/NN
was/VBD
selected/VBN
as/IN
the/DT
drug/NN
target/NN
./.
====================
The/DT
protein/NN
sequence/NN
of/IN
H1N1/NN
NA/NN
(/(
ID/NN
:/:
ADJ40637.1/NN
)/)
was/VBD
retrieved/VBN
from/IN
NCBI/NN
(/(
http/NN
:/:
//www.ncbi.nlm.nih.gov//JJ
)/)
./.
====================
Molecular/JJ
modelling/VBG
and/CC
structural/JJ
validation/NN
of/IN
drug/NN
target/NN
====================
Phyre2/NN
server/RB
was/VBD
used/VBN
for/IN
modeling/VBG
of/IN
the/DT
tertiary/JJ
structure/NN
of/IN
NA/NN
protein/NN
./.
====================
It/PRP
predict/VBP
the/DT
three-dimensional/JJ
(/(
3D/NN
)/)
structure/NN
of/IN
a/DT
protein/NN
sequence/NN
using/VBG
the/DT
principles/NNS
and/CC
techniques/NNS
of/IN
homology/NN
modeling/VBG
./.
====================
Because/IN
the/DT
structure/NN
of/IN
a/DT
protein/NN
is/VBZ
more/RBR
conserved/VBN
in/IN
evolution/NN
than/IN
its/PRP$
amino/NN
acid/NN
sequence/NN
,/,
a/DT
protein/NN
sequence/NN
of/IN
interest/JJ
(/(
the/DT
target/NN
)/)
can/MD
be/VB
modeled/VBN
with/IN
reasonable/JJ
accuracy/NN
on/IN
a/DT
very/RB
distantly/RB
related/JJ
sequence/NN
of/IN
known/JJ
structure/NN
(/(
the/DT
template/JJ
)/)
,/,
provided/VBD
that/DT
the/DT
relationship/NN
between/IN
target/NN
and/CC
template/JJ
can/MD
be/VB
discerned/VBN
through/IN
sequence/NN
alignment/NN
[/(
19/CD
]/)
./.
====================
YASARA/NN
Energy/NN
Minimization/NN
Server/NN
[/(
20/CD
]/)
was/VBD
employed/VBN
for/IN
structural/JJ
refinement/JJ
and/CC
energy/NN
minimization/NN
of/IN
the/DT
predicted/VBN
model/NN
./.
====================
The/DT
refined/VBN
model/NN
reliability/NN
was/VBD
evaluated/VBN
through/IN
ProCheck/NN
[/(
21/CD
]/)
,/,
ProSA-web/NN
[/(
22/CD
]/)
,/,
ProQ/NN
[/(
23/CD
]/)
,/,
and/CC
ERRAT/NN
server/RB
[/(
24/CD
]/)
./.
====================
Ligand/NN
preparation/NN
and/CC
molecular/JJ
docking/NN
====================
Chemical/JJ
structures/NNS
of/IN
13/CD
natural/JJ
compounds/NNS
(/(
allicin/NN
,/,
ajoene/NN
,/,
andrographolide/CC
,/,
baicalin/NN
,/,
carvacrol/JJ
,/,
catechin/NN
,/,
coumarin/NN
,/,
curcumin/NN
,/,
menthol/JJ
,/,
eugenol/JJ
,/,
theaflavin/DT
,/,
tinosporon/NN
,/,
and/CC
ursolic/JJ
acid/NN
)/)
(/(
Fig/NN
./.
====================
1/CD
)/)
,/,
along/IN
with/IN
Chemical/JJ
Abstracts/NNS
Service/NN
registry/NN
numbers/NNS
,/,
reported/VBD
in/IN
the/DT
literature/NN
were/VBD
retrieved/VBN
from/IN
the/DT
PubChem/JJ
database/NN
(/(
Table/JJ
1/CD
)/)
[/(
25/CD
]/)
./.
====================
Both/DT
ligands/NNS
and/CC
receptor/NN
molecule/NN
(/(
H1N1/NN
NA/NN
)/)
was/VBD
prepared/VBN
in/IN
AutoDock4.2/NN
program/NN
[/(
26/CD
]/)
./.
====================
AutoDock/NN
is/VBZ
used/VBN
to/TO
predict/VB
small/JJ
molecule/NN
to/TO
the/DT
receptors/NNS
of/IN
known/VBN
3D/NN
structure/NN
./.
====================
The/DT
ligand/NN
and/CC
target/NN
protein/NN
were/VBD
given/VBN
as/IN
input/NN
and/CC
the/DT
flexible/JJ
docking/NN
was/VBD
performed/VBN
./.
====================
The/DT
negative/JJ
and/CC
low/JJ
value/NN
of/IN
ÎG/NN
bind/VBP
indicates/VBZ
strong/JJ
favorable/JJ
bonds/NNS
between/IN
protein/NN
and/CC
the/DT
novel/JJ
ligand/NN
indicating/VBG
that/IN
the/DT
ligand/NN
was/VBD
in/IN
its/PRP$
most/JJS
favorable/JJ
conformations/NNS
[/(
26/CD
]/)
./.
====================
Docking/VBG
studies/NNS
were/VBD
carried/VBN
out/RP
as/IN
per/FW
the/DT
normal/JJ
methodology/NN
for/IN
protein-ligand/NN
docking/NN
used/VBN
by/IN
Kumar/JJ
et/FW
al/JJ
./.
====================
[/(
27/CD
]/)
and/CC
Jagadeb/NN
et/FW
al/JJ
./.
====================
[/(
28/CD
]/)
./.
====================
Visualization/NN
====================
The/DT
visualization/NN
of/IN
structure/NN
files/NNS
was/VBD
done/VBN
using/VBG
the/DT
graphical/JJ
interface/NN
of/IN
the/DT
ADT/NN
tool/NN
and/CC
the/DT
schematic/JJ
diagrams/NNS
of/IN
protein-ligand/CC
interactions/NNS
was/VBD
prepared/VBN
using/VBG
the/DT
LigPlot/NN
[/(
29/CD
]/)
./.
====================
Structural/JJ
model/NN
and/CC
evaluation/NN
of/IN
NA/NN
receptor/NN
====================
NA/NN
protein/NN
of/IN
H1N1/NN
is/VBZ
of/IN
length/NN
of/IN
469/CD
amino/NN
acids/NNS
sequence/NN
./.
====================
Due/IN
to/TO
unavailability/NN
of/IN
experimentally/RB
determined/VBN
structure/NN
of/IN
selected/VBN
NA/NN
protein/NN
,/,
tertiary/JJ
structure/NN
was/VBD
predicted/VBN
using/VBG
the/DT
Phyre2/NN
web/NN
server/RB
./.
====================
Two/CD
templates/NNS
were/VBD
used/VBN
to/TO
predict/VB
the/DT
3D/NN
structures/NNS
of/IN
NA/NN
protein/NN
(/(
Fig/NN
./.
====================
2A/NN
)/)
,/,
such/JJ
as/IN
D/NN
chain/NN
of/IN
H5N1/NN
NA/NN
in/IN
complex/NN
with/IN
oseltamivir/JJ
(/(
Protein/NN
Data/NNS
Bank/NN
[/(
PDB/NN
]/)
ID/NN
:/:
2HU4/CD
)/)
[/(
30/CD
]/)
and/CC
D/NN
chain/NN
of/IN
I223R/NN
NA/NN
mutant/JJ
structure/NN
(/(
PDB/NN
ID/NN
:/:
4B7Q/CD
)/)
[/(
31/CD
]/)
./.
====================
The/DT
predicted/VBN
structure/NN
was/VBD
then/RB
subjected/VBD
to/TO
the/DT
YASARA/NN
Energy/NN
Minimization/NN
Server/NN
for/IN
structural/JJ
refinement/JJ
./.
====================
The/DT
total/JJ
energy/NN
for/IN
the/DT
refined/VBN
structure/NN
obtained/VBN
from/IN
the/DT
YASARA/NN
Energy/NN
Minimization/NN
Server/NN
for/IN
NA/NN
was/VBD
â194,023.8/CD
kJ/mol/NN
(/(
score/RB
,/,
â2.68/CD
)/)
where/WRB
prior/JJ
to/TO
energy/NN
minimization/NN
,/,
it/PRP
was/VBD
25,622,682,021,439/CD
kJ/mol/NN
(/(
score/RB
,/,
â7.17/CD
)/)
./.
====================
The/DT
stereochemistry/NN
of/IN
the/DT
refined/VBN
model/NN
of/IN
NA/NN
(/(
ProCheck/NN
analysis/NN
)/)
(/(
Fig/NN
./.
====================
2B/NN
)/)
revealed/VBD
that/IN
94.4/CD
%/NN
residues/NNS
were/VBD
situated/VBN
in/IN
the/DT
most/JJS
favorable/JJ
region/NN
and/CC
additional/JJ
allowed/VBD
regions/NNS
and/CC
1.8/CD
%/NN
of/IN
residues/NNS
were/VBD
in/IN
the/DT
generously/RB
allowed/VBD
region/NN
,/,
whereas/IN
3.8/CD
%/NN
the/DT
residues/NNS
fell/JJ
in/IN
the/DT
disallowed/JJ
region/NN
of/IN
the/DT
Ramachandran/NN
plot/NN
(/(
Fig/NN
./.
====================
2B/NN
)/)
./.
====================
ProSA-web/NN
evaluation/NN
revealed/VBD
a/DT
compatible/JJ
Z/NN
score/RB
value/NN
of/IN
NA/NN
was/VBD
obtained/VBN
to/TO
be/VB
â4.89/CD
(/(
Fig/NN
./.
====================
2C/NN
)/)
which/WDT
is/VBZ
well/RB
within/IN
the/DT
range/NN
of/IN
native/JJ
conformations/NNS
of/IN
crystal/JJ
structures/NNS
./.
====================
The/DT
overall/JJ
residual/JJ
energies/VBZ
of/IN
the/DT
NA/NN
tertiary/JJ
model/NN
were/VBD
largely/RB
negative/JJ
except/IN
for/IN
few/JJ
peaks/NNS
./.
====================
The/DT
3D/NN
model/NN
of/IN
H1N1/NN
NA/NN
protein/NN
showed/VBD
a/DT
Levitt-Gerstein/JJ
(/(
LG/NN
)/)
score/RB
of/IN
4.183/CD
and/CC
Maxus/JJ
0.060/CD
by/IN
Protein/NN
Quality/NN
Predictor/NN
(/(
ProQ/NN
)/)
tool/NN
,/,
implying/VBG
a/DT
high/JJ
accuracy/NN
level/NN
of/IN
the/DT
predicted/VBN
structure/NN
./.
====================
A/DT
ProQ/NN
LG/NN
score/RB
>/JJR
2.5/CD
is/VBZ
necessary/JJ
for/IN
suggesting/VBG
that/IN
a/DT
model/NN
is/VBZ
of/IN
very/RB
good/JJ
quality/NN
[/(
24/CD
]/)
./.
====================
Similar/JJ
assumptions/NNS
were/VBD
achieved/VBN
using/VBG
the/DT
ERRAT/NN
plot/NN
where/WRB
the/DT
overall/JJ
quality/NN
factor/NN
for/IN
NA/NN
was/VBD
observed/VBN
to/TO
be/VB
13.015/CD
(/(
Fig/NN
./.
====================
2D/CD
)/)
./.
====================
All/DT
of/IN
these/DT
outcomes/NNS
recommended/VBN
the/DT
reliability/NN
of/IN
the/DT
proposed/JJ
model/NN
./.
====================
Docking/VBG
analysis/NN
of/IN
H1N1/NN
NA/NN
with/IN
natural/JJ
ligands/NNS
====================
Few/JJ
earlier/RBR
in/IN
silico/NN
docking/NN
studies/NNS
conducted/VBD
against/IN
NA/NN
protein/NN
with/IN
zanamivir/JJ
,/,
oseltamivir/JJ
and/CC
some/DT
natural/JJ
ligands/NNS
to/TO
recommend/VB
NA/NN
as/IN
a/DT
suitable/JJ
drug/NN
target/NN
as/IN
well/RB
as/IN
the/DT
importance/NN
of/IN
natural/JJ
inhibitors/NNS
[/(
3233/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
have/VBP
predicted/VBN
the/DT
structure/NN
of/IN
NA/NN
for/IN
docking/NN
analysis/NN
and/CC
found/VBD
that/IN
all/DT
natural/JJ
ligands/NNS
(/(
inhibitors/NNS
)/)
were/VBD
docked/VBN
in/IN
various/JJ
conformations/NNS
and/CC
with/IN
varying/VBG
binding/VBG
energies/VBZ
,/,
the/DT
lowest/JJS
energy/NN
conformation/NN
was/VBD
selected/VBN
./.
====================
Upon/IN
docking/NN
,/,
the/DT
high-ranked/JJ
binding/NN
energies/VBZ
of/IN
modeled/JJ
structures/NNS
of/IN
NA/NN
(/(
Table/JJ
2/CD
)/)
proteins/NNS
with/IN
natural/JJ
ligands/NNS
were/VBD
obtained/VBN
./.
====================
All/DT
the/DT
13/CD
active/JJ
natural/JJ
compounds/NNS
were/VBD
found/VBN
to/TO
interact/VB
with/IN
the/DT
receptor/NN
at/IN
the/DT
sialic/JJ
acid/NN
site/NN
(/(
Fig/NN
./.
====================
3AâM/NN
)/)
./.
====================
In/IN
our/PRP$
docking/NN
study/NN
,/,
among/IN
the/DT
13/CD
different/JJ
ligands/NNS
,/,
theaflavin/DT
showed/VBD
the/DT
lowest/JJS
binding/VBG
energy/NN
(/(
â5.21/CD
kcal/mol/NN
)/)
and/CC
inhibition/NN
constant/JJ
(/(
150.69/CD
ÂµM/NN
)/)
for/IN
the/DT
protein/NN
(/(
H1N1/NN
NA/NN
)/)
-ligand/CC
complex/NN
./.
====================
Theaflavin/DT
was/VBD
found/VBN
to/TO
interact/VB
with/IN
the/DT
amino/NN
acid/NN
residues/NNS
like/IN
Arg118/NN
,/,
Asp151/NN
,/,
Asp/NN
152/CD
,/,
Arg193/NN
,/,
Asp199/NN
,/,
Asn344/NN
,/,
and/CC
Arg430/NN
of/IN
NA/NN
by/IN
forming/VBG
hydrogen/NN
bonds/NNS
(/(
Fig/NN
./.
====================
3A/NN
)/)
./.
====================
Theaflavin/DT
and/CC
catechins/NNS
are/VBP
two/CD
active/JJ
polyphenolic/JJ
compounds/NNS
found/VBD
in/IN
green/CD
tea/NN
and/CC
reported/VBD
to/TO
have/VB
pronounced/VBN
antiviral/JJ
activity/NN
[/(
718/CD
]/)
./.
====================
Due/IN
to/TO
its/PRP$
ability/NN
to/TO
enhance/VB
humoral/JJ
and/CC
cell-mediated/JJ
immunity/NN
,/,
green/VBN
tea/NN
is/VBZ
very/RB
useful/JJ
for/IN
preventing/VBG
influenza/NN
by/IN
inhibiting/VBG
flu/NN
replication/NN
./.
====================
Further/RB
,/,
ursolic/JJ
acid/NN
showed/VBD
the/DT
second/JJ
lowest/JJS
binding/NN
energy/NN
of/IN
â4.97/CD
kcal/mol/NN
and/CC
an/DT
inhibition/NN
constant/JJ
of/IN
228.26/CD
ÂµM/NN
./.
====================
During/IN
docking/NN
with/IN
the/DT
receptor/NN
it/PRP
formed/VBD
two/CD
hydrogen/NN
bond/NN
with/IN
Asn146/NN
and/CC
Lys150/NN
of/IN
NA/NN
(/(
Fig/NN
./.
====================
3B/NN
)/)
./.
====================
Ursolic/JJ
acid/NN
is/VBZ
the/DT
active/JJ
component/NN
of/IN
O./NNP
sanctum/NN
(/(
tulsi/NNS
)/)
which/WDT
has/VBZ
great/JJ
ayurvedic/JJ
treatment/NN
option/NN
for/IN
swine/NN
flu/NN
and/CC
due/JJ
to/TO
its/PRP$
antimicrobial/JJ
properties/NNS
it/PRP
useful/JJ
for/IN
the/DT
prevention/NN
of/IN
novel/JJ
H1N1/NN
flu/NN
[/(
17/CD
]/)
./.
====================
The/DT
principal/JJ
components/NNS
of/IN
the/DT
oil/JJ
of/IN
M./NN
piperita/NN
are/VBP
menthol/JJ
(/(
29/CD
%/NN
)/)
,/,
menthone/NN
(/(
20/CD
%/NN
to/TO
30/CD
%/NN
)/)
,/,
and/CC
menthyl/JJ
acetate/NN
(/(
3/CD
%/NN
to/TO
10/CD
%/NN
)/)
./.
====================
Menthol/NN
has/VBZ
antimicrobial/JJ
and/CC
antiviral/JJ
activity/NN
and/CC
also/RB
observed/VBN
to/TO
have/VB
virucidal/JJ
against/IN
influenza/NN
,/,
herpes/RB
,/,
and/CC
other/JJ
viruses/NNS
in/IN
vitro/FW
[/(
11/CD
]/)
./.
====================
In/IN
our/PRP$
docking/NN
study/NN
,/,
the/DT
interaction/NN
binding/VBG
energy/NN
of/IN
menthol/JJ
and/CC
NA/NN
was/VBD
observed/VBN
to/TO
be/VB
â4.89/CD
kcal/mol/NN
with/IN
inhibition/NN
constant/JJ
of/IN
259.37/CD
ÂµM/NN
./.
====================
Further/RB
,/,
it/PRP
formed/VBD
four/CD
hydrogen/NN
bonds/NNS
with/IN
amino/NN
acid/NN
residues/NNS
(/(
Ile436/NN
,/,
Ile149/NN
,/,
Thr148/NN
,/,
and/CC
Gly147/NN
)/)
of/IN
NA/NN
(/(
Fig/NN
./.
====================
3C/NN
)/)
./.
====================
Further/RB
,/,
other/JJ
natural/JJ
compounds/NNS
like/IN
curcumin/NN
,/,
reported/VBD
to/TO
have/VB
strong/JJ
antioxidant/JJ
with/IN
anti-inflammatory/JJ
,/,
anti-viral/JJ
properties/NNS
[/(
15/CD
]/)
;/:
carvacrol/RB
,/,
the/DT
active/JJ
constituent/JJ
of/IN
the/DT
essential/JJ
oil/IN
from/IN
the/DT
fruit/JJ
of/IN
Trachyspermum/JJ
ammi/IN
[/(
8/CD
]/)
which/WDT
is/VBZ
used/VBN
for/IN
the/DT
treatment/NN
of/IN
colds/NNS
,/,
coughs/RB
,/,
influenza/RB
,/,
and/CC
asthma/NN
[/(
10/CD
]/)
;/:
allicin/RB
(/(
active/JJ
compounds/NNS
present/JJ
in/IN
ginger/CC
)/)
has/VBZ
been/VBN
reported/VBN
to/TO
have/VB
anti-influenza/JJ
cytokine/NN
[/(
13/CD
]/)
;/:
ajoene/RB
present/JJ
in/IN
garlic/JJ
and/CC
the/DT
garlic/JJ
has/VBZ
been/VBN
used/VBN
for/IN
hundreds/VBZ
of/IN
years/NNS
to/TO
treat/DT
fungal/JJ
,/,
parasitic/JJ
,/,
and/CC
viral/JJ
infections/NNS
,/,
and/CC
has/VBZ
anti-inflammatory/JJ
properties/NNS
and/CC
it/PRP
is/VBZ
reported/VBN
to/TO
kill/RB
influenza/NN
virus/NN
in/IN
vitro/FW
[/(
14/CD
]/)
./.
====================
Further/RB
,/,
curcumin/NN
,/,
tinosporon/NN
,/,
eugenol/JJ
,/,
catechin/NN
,/,
baicalin/NN
,/,
and/CC
andrographolide/CC
were/VBD
also/RB
found/VBD
to/TO
inhibit/VB
H1N1/NN
NA/NN
with/IN
significant/JJ
binding/NN
energy/NN
of/IN
in/FW
the/DT
range/NN
of/IN
â4.89/CD
to/TO
â4.0/CD
kcal/mol/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
The/DT
current/JJ
in/IN
silico/NN
docking/NN
study/NN
,/,
also/RB
observed/VBN
all/DT
these/DT
natural/JJ
ligands/NNS
inhibits/VBZ
H1N1/NN
NA/NN
with/IN
significant/JJ
binding/NN
energy/NN
(/(
Table/JJ
2/CD
)/)
./.
====================
All/DT
natural/JJ
ligands/NNS
were/VBD
reported/VBN
to/TO
block/VB
influenza/NN
infection/NN
;/:
our/PRP$
docking/NN
study/NN
also/RB
revealed/VBD
the/DT
in/FW
silico/NN
validation/NN
for/IN
the/DT
possible/JJ
mechanism/NN
of/IN
blocking/VBG
./.
====================
Most/JJS
of/IN
the/DT
natural/JJ
ligands/NNS
were/VBD
found/VBN
to/TO
interact/VB
with/IN
H1N1/NN
NA/NN
protein/NN
with/IN
effective/JJ
binding/NN
energy/NN
and/CC
with/IN
amino/NN
acid/NN
residues/NNS
known/VBN
for/IN
sialic/JJ
acid/NN
binding/NN
./.
====================
This/DT
interaction/NN
might/MD
prevent/VB
NA/NN
glycoprotein/NN
from/IN
interacting/VBG
with/IN
host/NN
sialic/JJ
acid/NN
,/,
which/WDT
may/MD
correlate/VB
with/IN
why/WRB
these/DT
natural/JJ
compounds/NNS
are/VBP
used/VBN
to/TO
prevent/VB
or/CC
treat/VB
against/IN
influenza/NN
without/IN
any/DT
adverse/JJ
effect/NN
./.
====================
All/DT
natural/JJ
ligands/NNS
were/VBD
reported/VBN
to/TO
block/VB
influenza/NN
infection/NN
;/:
our/PRP$
docking/NN
study/NN
also/RB
revealed/VBD
the/DT
in/FW
silico/NN
validation/NN
for/IN
the/DT
possible/JJ
mechanism/NN
of/IN
blocking/VBG
./.
====================
Most/JJS
of/IN
the/DT
natural/JJ
ligands/NNS
were/VBD
found/VBN
to/TO
interact/VB
with/IN
H1N1/NN
NA/NN
protein/NN
with/IN
effective/JJ
binding/NN
energy/NN
and/CC
with/IN
amino/NN
acid/NN
residues/NNS
known/VBN
for/IN
sialic/JJ
acid/NN
binding/NN
./.
====================
This/DT
interaction/NN
might/MD
prevent/VB
NA/NN
glycoprotein/NN
from/IN
interacting/VBG
with/IN
host/NN
sialic/JJ
acid/NN
,/,
which/WDT
may/MD
correlate/VB
with/IN
why/WRB
these/DT
natural/JJ
compounds/NNS
are/VBP
used/VBN
to/TO
prevent/VB
or/CC
treat/VB
against/IN
influenza/NN
without/IN
any/DT
adverse/JJ
effect/NN
./.
====================
In/IN
conclusion/NN
,/,
different/JJ
natural/herbal/JJ
products/NNS
with/IN
antiviral/JJ
activity/NN
have/VBP
been/VBN
traditionally/RB
used/VBN
to/TO
prevent/VB
or/CC
reduce/VB
the/DT
effects/NNS
of/IN
the/DT
viral/JJ
infection/NN
./.
====================
Most/JJS
of/IN
literature/NN
has/VBZ
given/VBN
stress/NN
on/IN
using/VBG
natural/JJ
products/NNS
of/IN
plant/JJ
origin/NN
./.
====================
It/PRP
is/VBZ
the/DT
time/NN
for/IN
in/IN
silico/NN
validation/NN
of/IN
those/DT
plant/JJ
products/NNS
against/IN
viral/JJ
proteins/NNS
before/IN
in/IN
vitro/FW
and/CC
in/IN
vivo/FW
study/NN
./.
====================
The/DT
major/JJ
antigenic/JJ
determinants/NNS
of/IN
H1N1/NN
virus/NN
is/VBZ
NA/NN
which/WDT
is/VBZ
a/DT
surface/NN
glycoprotein/NN
and/CC
is/VBZ
a/DT
suitable/JJ
target/NN
for/IN
H1N1/NN
./.
====================
Thus/RB
,/,
in/IN
order/NN
to/TO
prevent/VB
or/CC
cure/JJ
viral/JJ
infection/NN
,/,
there/EX
is/VBZ
need/VBN
to/TO
identify/VB
new/JJ
inhibitors/NNS
against/IN
NA/NN
./.
====================
The/DT
in/IN
silico/NN
docking/NN
approaches/NNS
used/VBN
in/IN
this/DT
study/NN
revealed/VBD
the/DT
molecular/JJ
interaction/NN
of/IN
natural/JJ
ligands/NNS
against/IN
NA/NN
protein/NN
which/WDT
may/MD
be/VB
of/IN
interest/NN
in/IN
designing/VBG
new/JJ
drugs/NNS
from/IN
natural/JJ
sources/NNS
against/IN
H1N1/NN
./.
====================
Out/CC
of/IN
all/DT
the/DT
inhibitors/NNS
molecules/NNS
,/,
Theaflavin/NNP
has/VBZ
been/VBN
docked/VBN
with/IN
minimum/JJ
binding/VBG
energy/NN
of/IN
â5.21/NN
kcal/mol/NN
by/IN
forming/VBG
hydrogen/NN
bonding/VBG
with/IN
amino/NN
acid/NN
residue/NN
of/IN
the/DT
receptor/NN
can/MD
be/VB
consider/RBR
for/IN
in/IN
vitro/FW
and/CC
in/IN
vivo/FW
validation/NN
./.
====================
Chemical/JJ
structures/NNS
of/IN
natural/JJ
compounds/NNS
./.
====================
(/(
A/NN
)/)
Ajoene/NN
./.
====================
(/(
B/NN
)/)
Allicin/NN
./.
====================
(/(
C/NN
)/)
Andrographolide/NN
./.
====================
(/(
D/NN
)/)
Baicalin/NN
./.
====================
(/(
E/NN
)/)
Carvacrol/NN
./.
====================
(/(
F/NN
)/)
Catechin/NN
./.
====================
(/(
G/NN
)/)
Coumarin/NN
./.
====================
(/(
H/NN
)/)
Curcumin/NN
./.
====================
(/(
I/NN
)/)
Menthol/NN
./.
====================
(/(
J/NN
)/)
Eugenol/NN
./.
====================
(/(
K/NN
)/)
Theaflavin/NN
./.
====================
(/(
L/NN
)/)
Tinosporon/NN
./.
====================
(/(
M/NN
)/)
Ursolic/JJ
acid/NN
./.
====================
(/(
A/NN
)/)
Predicted/JJ
protein/NN
structure/NN
of/IN
neuraminidase/NN
(/(
NA/NN
)/)
./.
====================
(/(
B/NN
)/)
Ramachandran/NN
plot/NN
of/IN
predicted/VBN
NA/NN
model/NN
(/(
the/DT
red/JJ
,/,
dark/VBP
yellow/RB
,/,
and/CC
light/JJ
yellow/RB
regions/NNS
represent/VBP
the/DT
most/JJS
favored/VBD
,/,
allowed/VBD
,/,
and/CC
generously/RB
allowed/VBD
regions/NNS
)/)
./.
====================
(/(
C/NN
)/)
ProSA-web/NN
Z-scores/NNS
of/IN
NA/NN
(/(
all/DT
protein/NN
chains/NNS
in/IN
Protein/NN
Data/NNS
Bank/NN
[/(
PDB/NN
]/)
determined/VBN
by/IN
X-ray/NN
crystallography/NN
[/(
light/JJ
blue/JJ
]/)
and/CC
nuclear/JJ
magnetic/JJ
resonance/NN
spectroscopy/NN
[/(
dark/VBP
blue/JJ
]/)
with/IN
respect/NN
to/TO
their/PRP$
length/NN
)/)
./.
====================
(/(
D/NN
)/)
ERRAT/NN
plot/NN
of/IN
NA/NN
for/IN
residue-wise/JJ
analysis/NN
of/IN
homology/NN
model/NN
./.
====================
NMR/NN
,/,
nuclear/JJ
magnetic/JJ
resonance/NN
./.
====================
aOn/IN
the/DT
error/NN
axis/NN
,/,
two/CD
lines/NNS
are/VBP
drawn/VBN
to/TO
indicate/VB
the/DT
confidence/NN
with/IN
which/WDT
it/PRP
is/VBZ
possible/JJ
to/TO
reject/VB
regions/NNS
that/IN
exceed/VBP
that/DT
error/VBP
value/NN
./.
====================
Interaction/NN
profile/NN
of/IN
all/DT
13/CD
natural/JJ
ligands/NNS
with/IN
neuraminidase/NN
showing/VBG
interaction/NN
of/IN
ligands/NNS
with/IN
the/DT
active/JJ
site/NN
residues/NNS
of/IN
receptors/NNS
by/IN
forming/VBG
hydrogen/NN
bonds/NNS
drawn/VBN
by/IN
LigPlot/NN
./.
====================
(/(
A/NN
)/)
Theaflavin/NN
./.
====================
(/(
B/NN
)/)
Ursolic/JJ
acid/NN
./.
====================
(/(
C/NN
)/)
Menthol/NN
./.
====================
(/(
D/NN
)/)
Curcumin/NN
./.
====================
(/(
E/NN
)/)
Tinosporone/NN
./.
====================
(/(
F/NN
)/)
Eugenol/NN
./.
====================
(/(
G/NN
)/)
Catechin/NN
./.
====================
(/(
H/NN
)/)
Baicalin/NN
./.
====================
(/(
I/NN
)/)
Andrographolide/NN
./.
====================
(/(
J/NN
)/)
Carvacrol/NN
./.
====================
(/(
K/NN
)/)
Coumarin/NN
./.
====================
(/(
L/NN
)/)
Alicin/NN
./.
====================
(/(
M/NN
)/)
Ajoene/NN
./.
====================
Natural/JJ
compounds/NNS
reported/VBD
to/TO
use/VB
against/IN
influenza/NN
====================
Polar/JJ
contact/NN
information/NN
from/IN
docking/NN
calculations/NNS
between/IN
ligands/NNS
and/CC
neuraminidase/NN
protein/NN
====================
